Pediatric Oncology

1. Front Matter

   Pages i-xv

   PDF

2. Acute Leukemia

   • Michael E. Rytting, Mary S. Choroszy, Demetrios Petropoulos, Ka Wah Chan

   Pages 1-17

3. Hodgkin Lymphoma and Non-Hodgkin Lymphoma

   • Ka Wah Chan, Demetrios Petropoulos, Eric L. Chang, Michael E. Rytting

   Pages 18-29

4. Brain Tumors: Diagnosis, Surgery and Radiotherapy, and Supportive Care

   • Joann L. Ater, Jeffrey S. Weinberg, Moshe H. Maor, Bartlett D. Moore III, Donna R. Copeland

   Pages 30-49

5. Brain Tumors: Chemotherapy and Investigational Therapy

   • Joann L. Ater, Jeffrey S. Weinberg, Moshe H. Maor, Demetrios Petropoulos

   Pages 50-69

6. Wilms’ Tumor

   • Norman Jaffe, Margaret G. Pearson

   Pages 70-81

7. Neuroblastoma

   • Joann L. Ater, Laura L. Worth

   Pages 82-95

8. Soft-Tissue Tumors

   • R. Beverly Raney, Richard J. Andrassy, Martin Blakely, Tina V. Fanning, Moshe H. Maor, John Stewart

   Pages 96-109

9. Osteosarcoma

   • Norman Jaffe, Margaret G. Pearson

   Pages 110-120

10. Ewing’s Sarcoma

    • Cynthia E. Herzog, Anita Mahajan, Valerae O. Lewis

    Pages 121-141

11. Retinoblastoma

    • Misha Faustina, Cynthia E. Herzog, Dan S. Gombos

    Pages 142-154

12. Differentiated Thyroid Cancer

    • Rena Vassilopoulou-Sellin

    Pages 155-166

13. Medullary Thyroid Carcinoma

    • Robert F. Gagel

    Pages 167-179

14. Melanoma

    • Cynthia E. Herzog, Hafeez Diwan, Merrick I. Ross, Victor G. Prieto

    Pages 180-193

15. Novel Therapeutic Approaches

    • Sima S. Jeha, Laura L. Worth

    Pages 194-207

16. Supportive Care: Myelosuppression

    • Nidra I. Rodriguez Cruz, Renee M. Madden, Craig A. Mullen

    Pages 208-217

17. Supportive Care: Symptom Control

    • Renee M. Madden, Susannah E. Koontz-Webb, Donna S. Zhukovsky, Craig A. Mullen

    Pages 218-243

18. Behavioral Medicine in Cancer Care

    • Donna R. Copeland, Martha A. Askins

    Pages 244-255

19. The Adolescent and Young Adult Program

    • Sima S. Jeha, Martha A. Askins

    Pages 256-267

20. Back Matter

    Pages 268-287

    PDF

Childhood cancer was almost always fatal before 1970. Today, 80% of ch- dren diagnosed with cancer will survive at least 5 years; 70% will be cured. However, cancer continues to be the leading cause of nonaccident-related deaths in children. More children die each year from cancer than from c- tic ?brosis, diabetes, asthma, AIDS, and congenital abnormalities combined. Nine children die from cancer every school day. Despite the fact that pediatric cancers account for only a small p- centage of the total cancer burden, more effective therapies are needed to improve mortality rates in children. Therefore, our research priority must be the development of new agents and new therapies for childhood cancer. M. D. Anderson Cancer Center has been caring for children with c- cer since its doors opened over 60 years ago. This institution has been home to several research and clinical pioneers whose innovative work has in?uenced and shaped the practice of pediatric oncology throughout the world. Notably, Drs. Wataru W. Sutow, Donald Pinkel, and Norman Jaffe have been credited with introducing curative therapies for children with leukemia and solid tumors. Cancer treatment involves far more than administering chemoth- apy and surgically excising tumors. It requires a multidisciplinary - proach to patient management, particularly in the treatment of solid - mors, which pose the biggest challenge in cancer care today. Surgery and radiotherapy as well as radiographic and pathologic assessments of response are critical factors in the treatment of children with cancer.

• brain tumors
• carcinoma
• childhood
• leukemia
• lymphoma
• melanoma
• radiotherapy
• surgery
• tumor

• M. D. Anderson Cancer Center, The University of Texas, Houston, USA

  Ka Wah Chan, R. Beverly Raney

Policies and ethics